PCMA Supports Bipartisan REMEDY Act to Reduce Drug Prices
April 12, 2019
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on bipartisan legislation introduced...
PCMA: Greater Competition on Insulin Products Key to Reducing Prices
April 10, 2019
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) applauds the Energy and Commerce Subcommittee on Oversight and Investigations for...
Independent Drugstore Lobby Agenda Increases Prescription Drug Costs in Pennsylvania
April 09, 2019
(Washington, D.C.) — As independent drugstore lobbyists descend on Harrisburg for their lobby day, the Pharmaceutical Care Management Association (PCMA) released the...
OUR NEXT CONFERENCE
PCMA Annual Meeting
September 23 & 24, 2019
Scottsdale, AZ
Join us for the industry’s premier executive conference. The event is tailored specifically for senior executives from PBMs and their affiliated business partners – most notable drug manufacturers.
Learn MoreABOUT OUR INDUSTRY
PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others. PBMs are projected to save employers, unions, government programs, and consumers $654 billion— up to 30 percent—on drug benefit costs over the next decade.